Literature DB >> 19910931

Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.

Gang Wang1, Bonnie Ching-Ha Kwan, Fernand Mac-Moune Lai, Paul Cheung-Lung Choi, Kai-Ming Chow, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT).
METHODS: We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls.
RESULTS: The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = -0.374, P = 0.007) and miR-205 (r = -0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429.
CONCLUSIONS: The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910931     DOI: 10.1038/ajh.2009.208

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  58 in total

Review 1.  MicroRNAs in kidney development: lessons from the frog.

Authors:  Oliver Wessely; Raman Agrawal; Uyen Tran
Journal:  RNA Biol       Date:  2010-05-02       Impact factor: 4.652

Review 2.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease.

Authors:  Johan M Lorenzen; Hermann Haller; Thomas Thum
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

Review 3.  Translational study of microRNAs and its application in kidney disease and hypertension research.

Authors:  Alison J Kriegel; Domagoj Mladinov; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

Review 4.  Epigenetics of progression of chronic kidney disease: fact or fantasy?

Authors:  Maria R Wing; Ali Ramezani; Harindarpal S Gill; Joseph M Devaney; Dominic S Raj
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

5.  Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice.

Authors:  Yong Zhang; Hou-Qin Xiao; Yang Wang; Zhuo-Shun Yang; Long-Jun Dai; Yan-Cheng Xu
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

Review 6.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 7.  A perspective on chronic kidney disease progression.

Authors:  Jianyong Zhong; Hai-Chun Yang; Agnes B Fogo
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-14

Review 8.  Genomic biomarkers for chronic kidney disease.

Authors:  Wenjun Ju; Shahaan Smith; Matthias Kretzler
Journal:  Transl Res       Date:  2012-02-09       Impact factor: 7.012

9.  Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN).

Authors:  Kang Cheng; Partab Rai; Andrei Plagov; Xiqian Lan; Peter W Mathieson; Moin A Saleem; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2013-04-21       Impact factor: 3.905

10.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.